| Model‐based reverse translation between veterinary and human medicine: the one health initiative B Schneider, V Balbas‐Martinez, AE Jergens, IF Troconiz, K Allenspach, ... CPT: Pharmacometrics & Systems Pharmacology 7 (2), 65-68, 2018 | 45 | 2018 |
| A systems pharmacology model for inflammatory bowel disease V Balbas-Martinez, L Ruiz-Cerdá, I Irurzun-Arana, I Gonzalez-Garcia, ... PLoS One 13 (3), e0192949, 2018 | 36 | 2018 |
| Physiologically-based pharmacokinetic model for ciprofloxacin in children with complicated urinary tract infection V Balbas-Martinez, R Michelet, AN Edginton, K Meesters, IF Trocóniz, ... European Journal of Pharmaceutical Sciences 128, 171-179, 2019 | 14 | 2019 |
| A quantitative systems pharmacology model for the key interleukins involved in Crohn's disease V Balbas-Martinez, E Asin-Prieto, ZP Parra-Guillen, IF Troconiz Journal of Pharmacology and Experimental Therapeutics 372 (3), 299-307, 2020 | 12 | 2020 |
| Systems Pharmacology model for Inflammatory Bowel Disease (IBD) V Balbas-Martinez, L Ruiz-Cerdá, I Irurzun-Arana, I González-García, ... International Conference on Systems Biology, 2016 | 2 | 2016 |
| Towards Mechanistic Characterization of Inflamatory Bowel Diseases and Complicated Urinary Tract Infection using Systems Pharmacology Approach V Balbás-Martínez | | 2020 |
| Physiologically-Based Pharmacokinetic model for Ciprofloxacin in children with complicated Urinary Tract Infection (vol 128, pg 171, 2019) V Balbas-Martinez, R Michelet, AN Edginton, K Meesters, IF Troconiz, ... EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES 143, 2020 | | 2020 |
| KN Reverse translational pharmacology: paradigm shift or flash in the pan? JP Mochel, AE Jergens, I Troconiz, V Balbas-Martinez, S Benzekry, ... JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS 41, 14-15, 2018 | | 2018 |
| Development of a Quantitative Systems Pharmacology model in Crohn’s V Balbas-Martinez, E Asin-Prieto, Z Parra-Guillen (1) Pharmacometrics & Systems Pharmacology; Department of Pharmaceutical …, 1 | | 1 |
| Supplementary material: A Quantitative Systems Pharmacology model for the key Interleukins involved in Crohn's Disease. V Balbas-Martinez, E Asin-Prieto, ZP Parra-Guillen, IF Troconiz | | |
| Population Approach Group Europe Population Approach Group Europe R Hoare | | |
| Population Approach Group Europe Population Approach Group Europe V Balbas-Martinez | | |
| Population Approach Group Europe Population Approach Group Europe V Balbas-Martinez | | |
